Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders (NCT06252948) | Clinical Trial Compass
RecruitingNot Applicable
Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
United States240 participantsStarted 2021-12-29
Plain-language summary
A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosed with POEMS syndrome (newly diagnosed or in remission) or with newly diagnosed multiple myeloma (MM), monoclonal gammopathy of undetermined significance (MGUS), amyloid light chain (AL) amyloidosis or healthy controls from their households
Exclusion Criteria:
* Age under 18 years
* Pregnancy
* Substance abuse
* Antibiotics use or gastrointestinal endoscopy in the 3 months prior to the study participation
* Chronic gastrointestinal disorder
* Gastrointestinal surgeries in the past 2 years
* Chemotherapy (including anti-plasma cell treatment and steroids) or radiation treatment for cancer within the last 2 years or active cancer (other than plasma cell disorder)
What they're measuring
1
Gut Microbiome characteristics in patients with POEMS syndrome and other plasma cell disorders